Infections after Biologic Agent Therapy in rheumatic diseases

Infections after Biologic Agent Therapy in rheumatic diseases

Bibliographic Details
Main Authors:	S. Kinikli, G. Kinikli, O. Kucuksahin, M. Turgay, A. Ates
Format:	Article
Language:	English
Published:	Elsevier 2014-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971214011989

Similar Items

Tuberculosis in patients with ankylosing spondylitis treated with anti tumor necrosis factor
by: G. Kinikli, et al.
Published: (2014-04-01)

Infection and Immune System
by: Sami KINIKLI, et al.
Published: (1996-06-01)

Treatment Resistant Severe Digital Ischemia Associated with Antiphospholipid Syndrome in a Male Patient with Systemic Sclerosis
by: Orhan Küçükşahin, et al.
Published: (2014-01-01)

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases
by: C. Bazzani, et al.
Published: (2011-09-01)

TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES
by: B. S. Belov, et al.
Published: (2016-12-01)

Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease
by: Courtney L. Kraus, et al.
Published: (2012-01-01)

TARDY IDEAS ON THE USE OF BIOLOGICAL AGENTS IN RHEUMATIC DISEASES
by: Yu. V. Muravyev, et al.
Published: (2016-07-01)

IMPACT OF THERAPY WITH BIOLOGICAL AGENTS ON B-LYMPHOCYTE SUBPOPULATIONS IN RHEUMATIC DISEASES: NEW EVIDENCE
by: E. V. Suponitskaya, et al.
Published: (2015-03-01)

A short history of anti-rheumatic therapy - VII. Biological agents
by: B. Gatto, et al.
Published: (2011-11-01)

New horizons in the use of biological agents during pregnancy in patients with rheumatic disease
by: P A Shesternya, et al.
Published: (2017-05-01)

DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01)

Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
by: Cristiana Sieiro Santos, et al.
Published: (2021-04-01)

Current Therapy of Emergencies in Rheumatic Diseases
by: V.I. Denysiuk, et al.
Published: (2013-02-01)

Chlamydial infection in rheumatic diseases
by: S V Shubin, et al.
Published: (2008-02-01)

Management of infections in rheumatic patients receiving biological therapies. The Portuguese Society of Rheumatology recommendations.
by: Teixeira L, et al.
Published: (2016-12-01)

Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01)

Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases
by: Geri Guillaume, et al.
Published: (2011-11-01)

Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases
by: S V Moiseev, et al.
Published: (2013-05-01)

Invasive fungal infections in children with rheumatic diseases
by: O. P. Kozlova, et al.
Published: (2021-01-01)

Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases
by: Florian Berghea, et al.
Published: (2021-08-01)

Management of infections in rheumatic patients receiving biological therapies. The Portuguese Society of Rheumatology recommendations.
by: Lídia Teixeira, et al.
Published: (2016-10-01)

OPTIMIZATION OF HEALTHCARE FOR CHILDREN WITH RHEUMATIC DISEASES IN EPOCH OF TREATMENT WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS (BY THE EXAMPLE OF THE REPUBLIC OF BASHKORTOSTAN)
by: G. A. Shebaev, et al.
Published: (2013-12-01)

Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain
by: Nolla JM, et al.
Published: (2016-06-01)

Rheumatic diseases and viral infection: is there an association?
by: R. M. Balabanova
Published: (2020-11-01)

Lower respiratory tract infections in rheumatic diseases
by: B. S. Belov, et al.
Published: (2018-04-01)

A Cause of Fever of Unknown Origin: A Case of Adult Onset Still’s Disease
by: Gül Ruhsar YILMAZ, et al.
Published: (2007-03-01)

Costs of treatment with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in rheumatic diseases – data from the Romanian Registry of Rheumatic Diseases
by: Catalin Codreanu, et al.
Published: (2020-03-01)

Place of cyclosporin A in the therapy of rheumatic diseases
by: Zemfira Sadullaevna Alekberova, et al.
Published: (2011-09-01)

Biological therapy and development of neoplastic disease in patients with juvenile rheumatic disease: a systematic review
by: Vanessa Patricia L. Pereira, et al.

RHEUMATIC DISEASES AND TUBERCULOSIS INFECTION IN CHILDREN AND ADULTS
by: G. V. Santalova, et al.
Published: (2019-03-01)

Rheumatoid arthritis in real clinical practice: initiation of therapy with biological agents. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-II») project
by: V. N. Amirdzhanova, et al.
Published: (2019-09-01)

Biologic agents in immune-mediated inflammatory rheumatic diseases: current state of the art and clinical practice in Romania
by: A. Balanesc, et al.
Published: (2017-09-01)

Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases
by: Luisa Brites, et al.
Published: (2019-10-01)

The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
by: Reimold AM
Published: (2012-05-01)

HTLV-1 Infection and Rheumatic Diseases
by: Kunihiko Umekita, et al.
Published: (2020-02-01)

Cytomegalovirus infection in pediatric rheumatic diseases: a review
by: Wolf Dana G, et al.
Published: (2010-05-01)

Current aspects of glucocorticoid therapy of rheumatic diseases. Pulse-therapy
by: S K Solov'ev, et al.
Published: (2009-06-01)

Role of biomarkers in the diagnosis of bacterial infections in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-07-01)

Studies in drug therapy of the chronic rheumatic diseases, with special reference to Indomethacin, an anti-inflammatory agent
by: Boardman, P. L.
Published: (1966)

Use of disease-modifying anti-rheumatic drugs in the therapy of osteoarthritis
by: S. G. Anikin, et al.
Published: (2019-05-01)

Cannot write session to /tmp/vufind_sessions/sess_ufke0vgdkof8cscasejk9s6pgo